A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes

NCT00351507 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Vildagliptin

Sponsor

Novartis Pharmaceuticals